A Study of RX-10045 in the Treatment of Dry Eye Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye Syndrome

In brief

The primary purpose of this study is to assess the efficacy, tolerability and safety of RX-10045 Ophthalmic Solution in patients with Dry Eye Disease.

Key facts

Study ID

NCT01675570

Run by

C.T. Development America, Inc.

People needed

150

Starts

2012-08-01

Expected to finish

2012-11-01

Last updated by the study team

2013-02-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a patient reported history of dry eye in both eyes
• Presence of dry eye symptoms
• Presence of dry eye signs, destabilized tear film break-up time and corneal staining

You may not qualify if…

• Known contraindications or sensitivities to study medication or its components
• Any ocular condition that, in the opinion of the investigator, could affect the subject's safety or trial parameters
• Use of disallowed medication during the period indicated prior to the enrollment or during the study
• Be a female who is currently pregnant, planning a pregnancy, lactating, or not using a medically acceptable form of birth control

Where it is running

• Andover Eye Associates — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.